XyloCor Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • XyloCor Therapeutics's estimated annual revenue is currently $1.1M per year.(i)
  • XyloCor Therapeutics's estimated revenue per employee is $61,200

Employee Data

  • XyloCor Therapeutics has 18 Employees.(i)
  • XyloCor Therapeutics grew their employee count by 38% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M5714%N/AN/A
#2
$197.3M13828%N/AN/A
#3
$49.5M388-2%N/AN/A
#4
$19.2M1719%N/AN/A
#5
$5.3M58-8%N/AN/A
#6
$3.7M4522%N/AN/A
#7
$2.6M320%N/AN/A
#8
$0.3M50%N/AN/A
#9
$0.1M2-50%N/AN/A
#10
$2.5M31-6%N/AN/A
Add Company

XyloCor Therapeutics is a development-stage, biotechnology company dedicated to developing first-in-class gene therapies for patients with unmet medical need in cardiovascular disease.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$1.1M

Revenue (est)

38%

Employee Growth %

N/A

Valuation

N/A

Accelerator

XyloCor Therapeutics News

2022-04-06 - Gene Therapies & Associated Vectors 2022: Intellectual ...

DUBLIN, April 13, 2022 /PRNewswire/ -- The "Gene Therapies ... Wellstat Biologics; Xenetic Biosciences; XyloCor Therapeutics; Zycos.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M19-10%N/A
#2
$2.4M20-5%N/A
#3
$4.1M20-23%N/A
#4
$2.9M2018%N/A
#5
$1.8M21-9%N/A